Chase Investment Counsel’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
RP
Chase Investment Counsel's MEDP Position: Q3 2024 in Review
Chase Investment Counsel sold out of Medpace (MEDP) in Q3 2024, closing a stake of 9,012 shares — an estimated $3.71M sold.
Chase Investment Counsel first reported a position in MEDP in Q2 2023 and held it in 5 quarters. The position peaked at $3.71M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.
- Chase Investment Counsel reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
- Chase Investment Counsel sold 9,012 Medpace shares in Q3 2024, an estimated $3.71M.
- Chase Investment Counsel first reported a position in Medpace in Q2 2023 and held it in 5 quarters.
- Chase Investment Counsel's Medpace position peaked at $3.71M in Q2 2024.
- 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.
Based on Chase Investment Counsel's 13F filing for Q3 2024, filed 5 Nov 2024.